These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22044461)

  • 1. Antibody-directed neutralization of annexin II (ANX II) inhibits neoangiogenesis and human breast tumor growth in a xenograft model.
    Sharma M; Blackman MR; Sharma MC
    Exp Mol Pathol; 2012 Feb; 92(1):175-84. PubMed ID: 22044461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation.
    Sharma M; Ownbey RT; Sharma MC
    Exp Mol Pathol; 2010 Apr; 88(2):278-86. PubMed ID: 20079732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression.
    Sharma MR; Koltowski L; Ownbey RT; Tuszynski GP; Sharma MC
    Exp Mol Pathol; 2006 Oct; 81(2):146-56. PubMed ID: 16643892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy and downstream mechanism of anti-annexinA2 monoclonal antibody (anti-ANX A2 mAb) in a pre-clinical model of aggressive human breast cancer.
    Sharma MC; Tuszynski GP; Blackman MR; Sharma M
    Cancer Lett; 2016 Apr; 373(1):27-35. PubMed ID: 26797420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
    Sharma MR; Rothman V; Tuszynski GP; Sharma MC
    Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal Annexin II Promotes Angiogenesis and Breast Cancer Metastasis.
    Maji S; Chaudhary P; Akopova I; Nguyen PM; Hare RJ; Gryczynski I; Vishwanatha JK
    Mol Cancer Res; 2017 Jan; 15(1):93-105. PubMed ID: 27760843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target.
    Sharma MC; Sharma M
    Curr Pharm Des; 2007; 13(35):3568-75. PubMed ID: 18220793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
    Lamszus K; Jin L; Fuchs A; Shi E; Chowdhury S; Yao Y; Polverini PJ; Laterra J; Goldberg ID; Rosen EM
    Lab Invest; 1997 Mar; 76(3):339-53. PubMed ID: 9121117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annexin A2 (ANX A2): An emerging biomarker and potential therapeutic target for aggressive cancers.
    Sharma MC
    Int J Cancer; 2019 May; 144(9):2074-2081. PubMed ID: 30125343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel anti-denatured collagen humanized antibody D93 inhibits angiogenesis and tumor growth: An extracellular matrix-based therapeutic approach.
    Pernasetti F; Nickel J; Clark D; Baeuerle PA; Van Epps D; Freimark B
    Int J Oncol; 2006 Dec; 29(6):1371-9. PubMed ID: 17088974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
    Lobov S; Croucher DR; Saunders DN; Ranson M
    Thromb Haemost; 2008 Aug; 100(2):319-29. PubMed ID: 18690354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
    Arteaga CL; Hurd SD; Winnier AR; Johnson MD; Fendly BM; Forbes JT
    J Clin Invest; 1993 Dec; 92(6):2569-76. PubMed ID: 7504687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Important role of annexin A2 (ANXA2) in new blood vessel development in vivo and human triple negative breast cancer (TNBC) growth.
    Sharma MC; Jain D
    Exp Mol Pathol; 2020 Oct; 116():104523. PubMed ID: 32866522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of biomarkers modulating prostate cancer angiogenesis: differential expression of annexin II in prostate carcinomas from India and USA.
    Banerjee AG; Liu J; Yuan Y; Gopalakrishnan VK; Johansson SL; Dinda AK; Gupta NP; Trevino L; Vishwanatha JK
    Mol Cancer; 2003 Oct; 2():34. PubMed ID: 14613585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
    Prewett M; Huber J; Li Y; Santiago A; O'Connor W; King K; Overholser J; Hooper A; Pytowski B; Witte L; Bohlen P; Hicklin DJ
    Cancer Res; 1999 Oct; 59(20):5209-18. PubMed ID: 10537299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of the annexin II gene down-regulates the levels of S100A10, c-Myc, and plasmin and inhibits breast cancer cell proliferation and invasion.
    Zhang J; Guo B; Zhang Y; Cao J; Chen T
    Saudi Med J; 2010 Apr; 31(4):374-81. PubMed ID: 20383413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.
    Wu Y; Zhong Z; Huber J; Bassi R; Finnerty B; Corcoran E; Li H; Navarro E; Balderes P; Jimenez X; Koo H; Mangalampalli VR; Ludwig DL; Tonra JR; Hicklin DJ
    Clin Cancer Res; 2006 Nov; 12(21):6573-84. PubMed ID: 17085673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of VEGF for breast cancer angiogenesis in vivo: implications from intravital microscopy of combination treatments with an anti-VEGF neutralizing monoclonal antibody and doxorubicin.
    Borgström P; Gold DP; Hillan KJ; Ferrara N
    Anticancer Res; 1999; 19(5B):4203-14. PubMed ID: 10628376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.
    Roberts N; Kloos B; Cassella M; Podgrabinska S; Persaud K; Wu Y; Pytowski B; Skobe M
    Cancer Res; 2006 Mar; 66(5):2650-7. PubMed ID: 16510584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
    Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
    Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.